Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia - Image 1

£92.42

Springer Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Name: Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
Brand: Springer
Price: 92.42 GBP
Availability: InStock

Oncology

This is the usual price. Wait for it to drop, or tell us your number.

£92 today · usual range £0–£0 · best ever £85

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 579 days • 579 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 579 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £85 (375 days, 64.8%)

Price range: £85 - £108

Price levels: 5 different prices over 579 days

Description

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia provides a comprehensive understanding of the recent molecular genetics of Chronic Myelogenous Leukemia (CML) and a characterization of the molecular targets for drug development. Included are therapeutic implications, diagnosis, and prognosis for understanding and facilitating daily practice in the management of patients with CML. Understanding of the pathogenesis and therapy of hematological malignancies such as CML has grown significantly in recent years. This development owe much to the progress in molecular biology and now makes a major contribution to diagnosis and to treatment that pharmacologically targets the molecular events of CML. Molecular targeting therapy with newly developed agents such as small molecules and antibodies for hematological malignancies are being discovered after years of research. Some of these, including tyrosine kinase inhibitors such as imatinib, nilotinib, and dasatinib, lead to increased survival rates and improved therapies. With the opinion leaders of basic and clinical research in the field as authors, this book reviews recent advances in the biology of CML.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 4431562559
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 23 August 2016
Listed Since: 14 May 2016

Barcode

No barcode data available

Springer Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Chemotherapy for Leukemia: Novel Drugs and Treatment

Acute Myelogenous Leukemia (Contemporary Hematology)

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Leukemias

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Acute Myeloid Leukemia (Hematologic Malignancies)

The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Acute Leukemias (Hematologic Malignancies)

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Molecular Genetics and Therapy of Leukemia: 84 (Cancer Treatment and Research, 84)

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Leukemia and Related Disorders: Integrated Treatment Approaches (Contemporary Hematology)

Childhood Leukemias (Cambridge Medicine (Hardcover))

Humana Leukemia: Methods and Protocols: 538 (Molecular Biology)

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Pathogenesis and Treatment of Leukemia

Molecular Hematology

Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)

Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)